ECU
ROIV icon

Eisler Capital (UK)’s Roivant Sciences ROIV Stock Holding History

Eisler Capital (UK)’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-45,221
Closed -$66K – 380
2023
Q1 		$66K Hold
45,221
– – ﹤0.01% 248
2022
Q4 		$86.8K Buy
+45,221
New +$252K ﹤0.01% 89

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eisler Capital (UK)'s ROIV Position: Q2 2023 in Review

Eisler Capital (UK) sold out of Roivant Sciences (ROIV) in Q2 2023, closing a stake of 45,221 shares — an estimated $66K sold.

Eisler Capital (UK) first reported a position in ROIV in Q4 2022 and held it in 2 quarters. The position peaked at $86.8K in Q4 2022. 181 funds tracked by Wall St. Rank hold ROIV as of Q2 2023.

  • Eisler Capital (UK) reported no remaining Roivant Sciences position as of Q2 2023 after selling out during the quarter.
  • Eisler Capital (UK) sold 45,221 Roivant Sciences shares in Q2 2023, an estimated $66K.
  • Eisler Capital (UK) first reported a position in Roivant Sciences in Q4 2022 and held it in 2 quarters.
  • Eisler Capital (UK)'s Roivant Sciences position peaked at $86.8K in Q4 2022.
  • 181 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2023.

Based on Eisler Capital (UK)'s 13F filing for Q2 2023, filed 14 Aug 2023.